Seqens Seqens

X

Find Oxaliplatin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

Oxaliplatin
Also known as: (1r,2r)-cyclohexane-1,2-diamine;oxalic acid;platinum, Foloxatine, L-platin, Oxaliplatin,(s), Oxaliplatin, solid, Gsox
Molecular Formula
C8H16N2O4Pt
Molecular Weight
399.31  g/mol
InChI Key
OGAPHRMCCQCJOE-BNTLRKBRSA-N

An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.
1 2D Structure

Oxaliplatin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum
2.1.2 InChI
InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/t5-,6-;;/m1../s1
2.1.3 InChI Key
OGAPHRMCCQCJOE-BNTLRKBRSA-N
2.1.4 Canonical SMILES
C1CCC(C(C1)N)N.C(=O)(C(=O)O)O.[Pt]
2.1.5 Isomeric SMILES
C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 1,2 Diaminocyclohexane Platinum Oxalate

2. 1,2-diaminocyclohexane Platinum Oxalate

3. 1,2-diamminocyclohexane(trans-1)oxolatoplatinum(ii)

4. Act 078

5. Act-078

6. Act078

7. Cis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(ii)

8. Eloxatin

9. L-ohp Cpd

10. Oxalato-(1,2-cyclohexanediamine)platinum Ii

11. Oxaliplatin

12. Oxaliplatin, (sp-4-2-(1r-trans))-isomer

13. Oxaliplatin, (sp-4-2-(1s-trans))-isomer

14. Oxaliplatin, (sp-4-3-(cis))-isomer

15. Oxaliplatine

16. Platinum(2+) Ethanedioate (1r,2r)-1,2-cyclohexanediamine (1:1:1)

17. Platinum(ii)-1,2-cyclohexanediamine Oxalate

2.2.2 Depositor-Supplied Synonyms

1. (1r,2r)-cyclohexane-1,2-diamine;oxalic Acid;platinum

2. Foloxatine

3. L-platin

4. Oxaliplatin,(s)

5. Oxaliplatin, Solid

6. Gsox

7. Mls000028569

8. Act-078

9. Hms2089p18

10. Akos015964329

11. Akos016016346

12. Ac-2110

13. Gs-3610

14. 111ge010

15. Smr000058995

16. Ab00698415-04

17. Ab00698415-05

18. 825o943

19. Brd-m14820059-001-04-0

20. Oxaliplatin, European Pharmacopoeia (ep) Reference Standard

21. Platinum(2+) Ion (1r,2r)-cyclohexane-1,2-diamine Oxalate

22. Oxaliplatin, United States Pharmacopeia (usp) Reference Standard

23. Oxaliplatin, Pharmaceutical Secondary Standard; Certified Reference Material

2.3 Create Date
2005-12-16
3 Chemical and Physical Properties
Molecular Weight 399.31 g/mol
Molecular Formula C8H16N2O4Pt
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count0
Exact Mass399.075801 g/mol
Monoisotopic Mass399.075801 g/mol
Topological Polar Surface Area127 Ų
Heavy Atom Count15
Formal Charge0
Complexity139
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


left grey arrow
right gray arrow
  • INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML)
  • INJECTABLE;INTRAVENOUS - 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML)
  • INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML)
  • INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML)
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY